No Health Without Rights: New Policy Brief Urges Universal Health Coverage for People Who Use Drugs in Europe
In support of the EU Drug Policy Campaign 2025, the Eurasian Harm Reduction Association (EHRA), together with the Correlation – European Harm Reduction Network (C-EHRN), the European Network of People Who Use Drugs (EuroNPUD), and the Drug Policy Network South East Europe (DPNSEE), has released a new policy brief: Advancing Universal Health Coverage for People Who Use Drugs in Europe.
The brief calls for urgent reforms to ensure equitable access to healthcare for one of the region’s most marginalized populations. It outlines how people who use drugs continue to face systemic barriers to essential services—including harm reduction, mental health care, and treatment for infectious diseases—despite longstanding EU commitments to Universal Health Coverage (UHC) and the Sustainable Development Goals.
“Universal health coverage must mean everyone—especially those most often left behind,” said Ganna Dovbakh, Executive Director at EHRA. “This paper is a roadmap for the EU and governments to close the gap between policy and practice.”
A policy webinar to discuss the brief’s findings and recommendations is planned for 10 October, marking World Mental Health Day.
The release of the brief aligns with the EU Drug Policy Campaign 2025, which calls on EU institutions to adopt a health- and rights-based approach in the upcoming EU Drug Strategy (2026–2030).
This publication is part of the EU-funded BOOST project, which supports community-led advocacy for inclusive health systems across Europe.
Read the full policy brief here
No Health Without Rights: New Policy Brief Urges Universal Health Coverage for People Who Use Drugs in Europe
In 2025, the European Union will adopt a new EU Drug Strategy that will define priorities for 2026–2030. As this critical moment approaches, we call for a shift towards a
EU Drug Policy Campaign 2025: A Call to Invest in a European Health-Based Drug Policy
In 2025, the European Union will adopt a new EU Drug Strategy that will define priorities for 2026–2030. As this critical moment approaches, we call for a shift towards a
BOOST at the 68th CND: Amplifying Advocacy for Health and Rights
From 10–14 March 2025, BOOST partners took part in the 68th session of the Commission on Narcotic Drugs (CND) in Vienna, using this global platform to advance strategic ad
Final Digital Expert Meeting: Defining Quality Standards for Digital Harm Reduction
On February 17-18, the final Digital Expert Meeting took place at the ISGlobal offices in Barcelona, bringing together experts in harm reduction and digital health to complete t
Shape the Future of Digital Harm Reduction – Join the 2nd Round of the Delphi Study
The BOOST project is working to establish quality standards for digital harm reduction services, supporting community-based and community-led organisations in providing eff
Call for applications for consultant to map availability, accessibility, and needs for Harm Reduction Services
Consultant to map availability, accessibility and needs for HarmReduction Services in Southeastern Europe Consultant to map availability, accessibility and needs for HarmReducti
Bring Your Expertise to Shape Digital Harm Reduction Quality Standards – Join the Delphi Study Call
Bring Your Expertise to Shape Digital Harm Reduction Quality Standards – Join the Delphi Study Digital harm reduction services are rapidly evolving, with a growing diversi
CLOSED: Call for applications for external evaluation of BOOST
The BOOST project, co-funded by an EU action grant and led by Correlation Network, aims to enhance the implementation of high-quality, community-based communicable disease servi
Join BOOST’s Peer-to-Peer Capacity-Building Webinar Series – Coming Nov 2024
As part of the BOOST Project, a series of webinars will be held in November for harm reduction organisations that are currently providing or planning to offer services in the fi
